Sara Sheikhbahaei

ORCID: 0000-0001-7866-4681
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Medical Imaging Techniques and Applications
  • Radiomics and Machine Learning in Medical Imaging
  • Global Health Care Issues
  • Prostate Cancer Treatment and Research
  • Head and Neck Cancer Studies
  • Global Public Health Policies and Epidemiology
  • Global Maternal and Child Health
  • Lung Cancer Diagnosis and Treatment
  • Radiopharmaceutical Chemistry and Applications
  • Climate Change and Health Impacts
  • Health disparities and outcomes
  • Prostate Cancer Diagnosis and Treatment
  • Pancreatic and Hepatic Oncology Research
  • Peptidase Inhibition and Analysis
  • Child Nutrition and Water Access
  • Salivary Gland Tumors Diagnosis and Treatment
  • Global Cancer Incidence and Screening
  • MRI in cancer diagnosis
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Gastroesophageal reflux and treatments
  • Glioma Diagnosis and Treatment
  • Renal cell carcinoma treatment
  • Breast Cancer Treatment Studies
  • Healthcare Systems and Reforms
  • Health Systems, Economic Evaluations, Quality of Life

Johns Hopkins University
2016-2025

National Institutes of Health
2016-2025

Emory University
2025

University of Alabama at Birmingham
2025

Johns Hopkins Medicine
2015-2024

Johns Hopkins Hospital
2021-2024

American University of Beirut
2022

Delhi Technological University
2022

University of Washington
2015-2022

Institute for Health Metrics and Evaluation
2015-2022

Brain and CNS cancers (collectively referred to as cancers) are a source of mortality morbidity for which diagnosis treatment require extensive resource allocation sophisticated diagnostic therapeutic technology. Previous epidemiological studies limited specific geographical regions or time periods, making them difficult compare on global scale. In this analysis, we aimed provide comparable comprehensive estimation the burden brain cancer between 1990 2016.We report means 95% uncertainty...

10.1016/s1474-4422(18)30468-x article EN cc-by The Lancet Neurology 2019-02-23

High prevalence of diabetes has been reported in the Americas, but no comprehensive analysis burden and related factors for region is available. We aimed to describe type 1 2 that hyperglycaemia Americas from 1990 2019.We used estimates GBD 2019 evaluate adults aged 20 years or older high fasting plasma glucose 25 39 countries territories six regions 2019. The main source estimate mortality attributable chronic kidney disease due was vital registration. Mortality overall (ie, disease)...

10.1016/s2213-8587(22)00186-3 article EN cc-by The Lancet Diabetes & Endocrinology 2022-07-15

The purpose of this study was to evaluate the value an 18 F-FDG PET/CT-based interpretation system (Hopkins criteria) assess therapy response and survival in lung cancer.Methods: This is Institutional Review Board-approved, retrospective study.A total 201 patients with biopsy-proven cancer, who underwent assessment PET/CT within 6 mo (mean, 7.5 wk) completion treatment, were included.Patients primarily treated surgical resection, chemotherapy, radiation therapy, or a combination these...

10.2967/jnumed.115.165480 article EN Journal of Nuclear Medicine 2016-02-02

The aim of this study was to evaluate the impact intratumoral metabolic heterogeneity and quantitative FDG PET/CT imaging parameters for predicting patient outcomes in primary oropharyngeal squamous cell cancer (OPSCC).

10.1097/rlu.0000000000001578 article EN Clinical Nuclear Medicine 2017-02-14

Radiotracers targeting prostate-specific membrane antigen (PSMA) have increasingly been recognized as showing uptake in a number of normal structures, anatomic variants, and non-prostate-cancer pathologies. We aimed to explore the frequency degree peripheral ganglia patients undergoing PET with PSMA-targeted agent 18F-DCFPyL.A total 98 who underwent 18F-DCFPyL PET/CT imaging were retrospectively analyzed. This included 76 men prostate cancer (PCa) 22 renal cell carcinoma (RCC; 13 men, 9...

10.1007/s12149-017-1201-4 article EN cc-by Annals of Nuclear Medicine 2017-08-22
Coming Soon ...